LILIAM SANTIESTEBAN: Open Payments
NPI 1114546611 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 5 payments from 3 companies in 2025. Trend: 2023 $1,527 · 2024 $1,336 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $136 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: REXULTI, UZEDY, INGREZZA, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
